SKYE•businesswire•January 9, 2026 at 10:47 PM

SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights

Summary

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage biopharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Skye Bioscience, Inc. (NASDAQ: SKYE) Misled Investors Regarding its Business Ope

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on January 9, 2026 by businesswire